Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 27 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Gene polymorphisms influence the risk of hepatocellular carcinoma

This week's Journal of the American Medical Association investigates epidermal growth factor gene functional polymorphisms and hepatocellular carcinoma risk in cirrhosis patients.

News image

fiogf49gjkf04

Overexpression of epidermal growth factor in the liver induces transformation to hepatocellular carcinoma in animal models.

Polymorphisms in the epidermal growth factor gene modulate epidermal growth factor levels.

Dr Kenneth Tanabe and colleagues from France assessed the relationship among human epidermal growth factor gene single-nucleotide polymorphism, epidermal growth factor expression, and risk of hepatocellular carcinoma.

There was a 4-fold odds of hepatocellular carcinoma in G/G patients
Journal of the American Medical Association

The team examined molecular mechanisms linking the 61*G allele polymorphism to epidermal growth factor expression in human hepatocellular carcinoma cell lines and human liver tissue.

The research team undertook a case-control study involving 207 patients with cirrhosis at the Massachusetts General Hospital between 1999 and 2006.

The researchers also conducted a validation case-control study involving 121 patients with cirrhosis at Hôpital Paul Brousse between 1993 and 2006.

The team used restriction fragment-length polymorphism to determine the epidermal growth factor gene polymorphism genotype.

Logistic regression analysis was used to assess the association between the epidermal growth factor polymorphism and hepatocellular carcinoma risk.

The researchers found mechanisms by which the epidermal growth factor gene polymorphism modulates epidermal growth factor levels.

The team also identified associations among epidermal growth factor gene polymorphism, epidermal growth factor levels, and hepatocellular carcinoma.

The researchers found that transcripts from the epidermal growth factor 61*G allele exhibited more than a 2-fold longer half-life than those from the 61*A allele.

The epidermal growth factor secretion was 2.3-fold higher in G/G hepatocellular carcinoma cell lines than A/A cell lines.

Serum epidermal growth factor levels were 1.8-fold higher in G/G patients than A/A patients, and liver epidermal growth factor levels were 2.4-fold higher in G/G patients than A/A patients.

The researchers noted that among the 207 patients with cirrhosis in the Massachusetts study population, 59 also had hepatocellular carcinoma.

Analysis of the distribution of allelic frequencies revealed that there was a 4-fold odds of hepatocellular carcinoma in G/G patients compared with A/A patients in the Massachusetts study population.

The team used logistic regression analysis to demonstrate that the number of copies of G was significantly associated with hepatocellular carcinoma.

This association remained significant after adjusting for age, sex, race, etiology, and severity of cirrhosis.

The significant association was validated in the French patients with alcoholic cirrhosis and hepatocellular carcinoma.

Dr Tanabe's team concluded, "The epidermal growth factor gene polymorphism genotype is associated with risk for development of hepatocellular carcinoma in liver cirrhosis through modulation of epidermal growth factor levels."

JAMA 2008: 299(1): 53-60
07 January 2008

Go to top of page Email this page Email this page to a colleague

 25 May 2018 
Colorectal cancer–specific mortality
 25 May 2018 
Technology to increase colorectal cancer screening
 25 May 2018 
Post‐operative complications in elderly IBD
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 24 May 2018 
Precision medicine for tumors
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
Hep B in the Grey Zone
 15 May 2018 
New therapies for CDI
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us